13-25372223-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016529.6(ATP8A2):āc.11G>Cā(p.Gly4Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000109 in 1,472,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_016529.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP8A2 | NM_016529.6 | c.11G>C | p.Gly4Ala | missense_variant | 1/37 | ENST00000381655.7 | NP_057613.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP8A2 | ENST00000381655.7 | c.11G>C | p.Gly4Ala | missense_variant | 1/37 | 1 | NM_016529.6 | ENSP00000371070 |
Frequencies
GnomAD3 genomes AF: 0.0000791 AC: 12AN: 151700Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000207 AC: 2AN: 96402Hom.: 0 AF XY: 0.0000186 AC XY: 1AN XY: 53764
GnomAD4 exome AF: 0.00000303 AC: 4AN: 1321200Hom.: 0 Cov.: 31 AF XY: 0.00000307 AC XY: 2AN XY: 651406
GnomAD4 genome AF: 0.0000791 AC: 12AN: 151700Hom.: 0 Cov.: 32 AF XY: 0.0000810 AC XY: 6AN XY: 74098
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2023 | The c.11G>C (p.G4A) alteration is located in exon 1 (coding exon 1) of the ATP8A2 gene. This alteration results from a G to C substitution at nucleotide position 11, causing the glycine (G) at amino acid position 4 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 10, 2021 | This sequence change replaces glycine, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 4 of the ATP8A2 protein (p.Gly4Ala). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ATP8A2-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The alanine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at